Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2015 Filed Mar 3, 2015 22:11 UTC |
Blaser Brian J.Executive Vice President
|
Tax withholdingCommon shares without par value | 12,276 | $47.61 | $584,460.36 |
DisclosureSEC source: 0001179110-15-004033 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,332 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:10 UTC |
ASHLEY RICHARD WExecutive Vice President
|
Tax withholdingCommon shares without par value | 18,529 | $47.61 | $882,165.69 |
DisclosureSEC source: 0001179110-15-004032 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,883 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:12 UTC |
CAPEK JOHN MExecutive Vice President
|
Tax withholdingCommon shares without par value | 12,312 | $47.61 | $586,174.32 |
DisclosureSEC source: 0001179110-15-004034 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,090 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:12 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 75,630 | $47.61 | $3,600,744.30 |
DisclosureSEC source: 0001179110-15-004036 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,470,433 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:13 UTC |
Simhambhatla Murthy VSenior Vice President
|
Tax withholdingCommon shares without par value | 5,709 | $47.61 | $271,805.49 |
DisclosureSEC source: 0001179110-15-004038 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,575 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:14 UTC |
Warmuth Michael JExecutive Vice President
|
Tax withholdingCommon shares without par value | 6,620 | $47.61 | $315,178.20 |
DisclosureSEC source: 0001179110-15-004040 · edgar.xml · nonDerivative · entry 2 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,933 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:14 UTC |
Warmuth Michael JExecutive Vice President
|
GrantCommon shares without par value | 24,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-004040 · edgar.xml · nonDerivative · entry 1 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,553 F1 · shares: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:15 UTC |
Foltz Charles DSenior Vice President
|
Tax withholdingCommon shares without par value | 4,737 | $47.61 | $225,528.57 |
DisclosureSEC source: 0001179110-15-004041 · edgar.xml · nonDerivative · entry 1 Foltz Charles D · CIK 0001573318 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,010 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:15 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Tax withholdingCommon shares without par value | 2,922 | $47.61 | $139,116.42 |
DisclosureSEC source: 0001179110-15-004043 · edgar.xml · nonDerivative · entry 1 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,448 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:16 UTC |
Ford Robert BSenior Vice President
|
Tax withholdingCommon shares without par value | 3,680 | $47.61 | $175,204.80 |
DisclosureSEC source: 0001179110-15-004045 · edgar.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,567 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:18 UTC |
Fussell Stephen RExecutive Vice President
|
Tax withholdingCommon shares without par value | 11,459 | $47.61 | $545,562.99 |
DisclosureSEC source: 0001179110-15-004047 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,601 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:17 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 22,797 | $47.61 | $1,085,365.17 |
DisclosureSEC source: 0001179110-15-004046 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,252 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:19 UTC |
DeVos Georges H.Senior Vice President
|
GrantCommon shares without par value | 4,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-004048 · edgar.xml · nonDerivative · entry 1 DeVos Georges H. · CIK 0001580246 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,129 F1 · shares: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:20 UTC |
Contreras JaimeSenior Vice President
|
Tax withholdingCommon shares without par value | 4,826 | $47.61 | $229,765.86 |
DisclosureSEC source: 0001179110-15-004049 · edgar.xml · nonDerivative · entry 1 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,107 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:21 UTC |
White J. ScottSenior Vice President
|
Tax withholdingCommon shares without par value | 8,144 | $47.61 | $387,735.84 |
DisclosureSEC source: 0001179110-15-004051 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,602 Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:30 UTC |
ALLEN HUBERT LExecutive Vice President
|
GrantOption (right to buy) · Derivative | 157,421 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003318 · edgar.xml · derivative · entry 2 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,421 Underlying: Common shares · 157,421 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 52,474 on 2/20/16, 52,473 on 2/20/17, and 52,474 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:30 UTC |
ALLEN HUBERT LExecutive Vice President
|
GrantCommon shares without par value | 22,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003318 · edgar.xml · nonDerivative · entry 1 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,281 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:32 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantOption (right to buy) · Derivative | 157,421 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003319 · edgar.xml · derivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,421 Underlying: Common shares · 157,421 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 52,474 on 2/20/16, 52,473 on 2/20/17, and 52,474 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:32 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantCommon shares without par value | 22,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003319 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,412 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:36 UTC |
Landgraf John CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 165,292 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003321 · edgar.xml · derivative · entry 4 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,292 Underlying: Common shares · 165,292 shares Expires 2025-02-19 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 55,098 on 2/20/16, 55,097 on 2/20/17, and 55,097 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:36 UTC |
Landgraf John CExecutive Vice President
|
GrantCommon shares without par value | 23,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003321 · edgar.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,502 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:40 UTC |
Pavee Jean-YvesSenior Vice President
|
GrantOption (right to buy) · Derivative | 146,551 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003326 · edgar.xml · derivative · entry 1 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,551 Underlying: Common shares · 146,551 shares Expires 2025-02-19 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 48,851 on 2/20/16, 48,850 on 2/20/17, and 48,850 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:37 UTC |
Mason Heather LExecutive Vice President
|
GrantOption (right to buy) · Derivative | 149,925 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003323 · edgar.xml · derivative · entry 2 Mason Heather L · CIK 0001432601 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,925 Underlying: Common shares · 149,925 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 49,975 on 2/20/16, 49,975 on 2/20/17, and 49,975 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:37 UTC |
Mason Heather LExecutive Vice President
|
GrantCommon shares without par value | 21,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003323 · edgar.xml · nonDerivative · entry 1 Mason Heather L · CIK 0001432601 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,710 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:41 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
GrantOption (right to buy) · Derivative | 127,436 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003328 · edgar.xml · derivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,436 Underlying: Common shares · 127,436 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 42,479 on 2/20/16, 42,478 on 2/20/17, and 42,479 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:41 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
GrantCommon shares without par value | 18,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003328 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,315 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:43 UTC |
Simhambhatla Murthy VSenior Vice President
|
GrantOption (right to buy) · Derivative | 127,436 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003331 · edgar.xml · derivative · entry 2 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,436 Underlying: Common shares · 127,436 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 42,479 on 2/20/16, 42,478 on 2/20/17, and 42,479 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:43 UTC |
Simhambhatla Murthy VSenior Vice President
|
GrantCommon shares without par value | 18,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003331 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,284 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:44 UTC |
Warmuth Michael JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 181,034 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003332 · edgar.xml · derivative · entry 1 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,034 Underlying: Common shares · 181,034 shares Expires 2025-02-19 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 60,345 on 2/20/16, 60,344 on 2/20/17, and 60,345 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:45 UTC |
White J. ScottSenior Vice President
|
GrantOption (right to buy) · Derivative | 121,064 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003333 · edgar.xml · derivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,064 Underlying: Common shares · 121,064 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 40,355 on 2/20/16, 40,354 on 2/20/17, and 40,355 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:45 UTC |
White J. ScottSenior Vice President
|
GrantCommon shares without par value | 17,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003333 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,746 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 937,031 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003334 · edgar.xml · derivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,031 Underlying: Common shares · 937,031 shares Expires 2025-02-19 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 312,344 on 2/20/16, 312,343 on 2/20/17, and 312,344 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantCommon shares without par value | 132,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003334 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,546,063 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:06 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
GrantOption (right to buy) · Derivative | 55,097 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003338 · edgar.xml · derivative · entry 5 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,097 Underlying: Common shares · 55,097 shares Expires 2025-02-19 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,366 on 2/20/16, 18,365 on 2/20/17, and 18,366 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:06 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
GrantCommon shares without par value | 7,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003338 · edgar.xml · nonDerivative · entry 1 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,370 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:08 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 284,857 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003340 · edgar.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,857 Underlying: Common shares · 284,857 shares Expires 2025-02-19 F7 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 94,953 on 2/20/16, 94,952 on 2/20/17, and 94,952 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:08 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantCommon shares without par value | 40,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003340 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,049 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:07 UTC |
Fussell Stephen RExecutive Vice President
|
GrantOption (right to buy) · Derivative | 169,227 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003339 · edgar.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,227 Underlying: Common shares · 169,227 shares Expires 2025-02-19 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 56,409 on 2/20/16, 56,409 on 2/20/17, and 56,409 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:07 UTC |
Fussell Stephen RExecutive Vice President
|
GrantCommon shares without par value | 24,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003339 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,060 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:14 UTC |
Foltz Charles DSenior Vice President
|
GrantOption (right to buy) · Derivative | 117,878 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003347 · edgar.xml · derivative · entry 3 Foltz Charles D · CIK 0001573318 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,878 Underlying: Common shares · 117,878 shares Expires 2025-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,293 on 2/20/16, 39,292 on 2/20/17, and 39,293 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:14 UTC |
Foltz Charles DSenior Vice President
|
GrantCommon shares without par value | 21,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003347 · edgar.xml · nonDerivative · entry 2 Foltz Charles D · CIK 0001573318 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,747 F2 · shares: These shares represent a retention award of restricted stock units under the Abbott Laboratories 2009 Incentive Stock Program. The award has an 18 month cliff vesting term. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:14 UTC |
Foltz Charles DSenior Vice President
|
GrantCommon shares without par value | 16,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003347 · edgar.xml · nonDerivative · entry 1 Foltz Charles D · CIK 0001573318 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,471 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:29 UTC |
Blaser Brian J.Executive Vice President
|
GrantOption (right to buy) · Derivative | 173,163 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003364 · edgar.xml · derivative · entry 2 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,163 Underlying: Common shares · 173,163 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 57,721 on 2/20/16, 57,721 on 2/20/17, and 57,721 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:29 UTC |
Blaser Brian J.Executive Vice President
|
GrantCommon shares without par value | 24,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003364 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,608 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:15 UTC |
DeVos Georges H.Senior Vice President
|
GrantOption (right to buy) · Derivative | 117,878 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003355 · edgar.xml · derivative · entry 1 DeVos Georges H. · CIK 0001580246 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,878 Underlying: Common shares · 117,878 shares Expires 2025-02-19 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,293 on 2/20/16, 39,292 on 2/20/17, and 39,293 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:31 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 165,292 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003367 · edgar.xml · derivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,292 Underlying: Common shares · 165,292 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 55,098 on 2/20/16, 55,097 on 2/20/17, and 55,097 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:31 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantCommon shares without par value | 23,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003367 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,402 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:32 UTC |
Contreras JaimeSenior Vice President
|
GrantOption (right to buy) · Derivative | 146,551 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003368 · edgar.xml · derivative · entry 6 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,551 Underlying: Common shares · 146,551 shares Expires 2025-02-19 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 48,851 on 2/20/16, 48,850 on 2/20/17, and 48,850 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:32 UTC |
Contreras JaimeSenior Vice President
|
GrantCommon shares without par value | 20,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003368 · edgar.xml · nonDerivative · entry 1 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,933 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 23:37 UTC |
Ford Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 127,436 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003369 · edgar.xml · derivative · entry 2 Ford Robert B · CIK 0001612571 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,436 Underlying: Common shares · 127,436 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 42,479 on 2/20/16, 42,478 on 2/20/17, and 42,479 on 2/20/18. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.